Digital Cardiovascular Medicine – Patient, Doctor, Devices

Cardiovascular Disease (CVD) remains the leading cause of death in the United States, and continued advances in invasive and noninvasive therapeutics abound. The need to bridge technologic advances with patient needs for remote ambulatory monitoring was underscored during the COVID-19 pandemic. Invasive pulmonary artery pressure sensors have highlighted the role of ambulatory hemodynamic monitoring in reducing the significant morbidity associated with chronic heart failure. Advances in electromechanical technology have led to renewed interest in developing unique pressure monitors in the other cardiac chambers, potentially allowing for precise hemodynamic monitoring tailored to disease and patient-specific states. Further adaptation of cardiac implantable electronic devices and noninvasive wearable technologies to detect lung congestion as a surrogate for impending decompensation have resulted in a wide variety of devices adaptable to unique patient preferences. The popularity in direct-to-consumer wearable health technologies have also added to the armamentarium of cardiovascular specialists in CVD screening and health promotion. We envision a future where such telemonitoring devices can be deployed to enhance patient-provider interactions, promote health equity, conduct pragmatic clinical studies and advance precision approaches to health care.